Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature

Cytokine release syndrome (CRS) is a phenomenon of immune hyperactivation described in the setting of immunotherapy. Unlike other immune-related adverse events, CRS triggered by immune checkpoint inhibitors (ICIs) is not well described. The clinical characteristics and course of 25 patients with ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Sen Hee, Toh, Michelle Min Xuan, Thian, Yee Liang, Vellayappan, Balamurugan A., Fairhurst, Anna-Marie, Chan, Yiong Huak, Aminkeng, Folefac, Bharwani, Lavina D., Huang, Yiqing, Mak, Anselm, Wong, Alvin Seng Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831742/
https://www.ncbi.nlm.nih.gov/pubmed/35154124
http://dx.doi.org/10.3389/fimmu.2022.807050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831742/
https://www.ncbi.nlm.nih.gov/pubmed/35154124
http://dx.doi.org/10.3389/fimmu.2022.807050

Ejemplares similares